The Depo-Provera Meningioma Lawsuit centers on allegations that prolonged use of the contraceptive injection Depo-Provera, which contains medroxyprogesterone acetate, increases the risk of developing meningiomas—slow-growing brain tumors arising from the meninges.
In October 2024, the first federal lawsuit was filed by a woman who used Depo-Provera between 2005 and 2021 and was subsequently diagnosed with a meningioma.
As more cases emerged, plaintiffs sought consolidation of these lawsuits into a multidistrict litigation (MDL) to streamline pretrial proceedings.
In February 2025, the U.S. Judicial Panel on Multidistrict Litigation (JPML) centralized 27 federal lawsuits into The Depo-Provera Multidistrict Litigation (MDL No. 3140), assigning them to Judge M. Casey Rodgers in the Northern District of Florida.
This MDL aims to efficiently handle the growing number of cases alleging that long-term Depo-Provera usage led to meningioma development.
Plaintiffs claim that Pfizer failed to provide adequate warnings about these risks, despite studies indicating a significant association between the Depo-Provera shot and brain tumors.
Women who have filed federal lawsuits in the Depo-Provera MDL seek compensation for medical expenses, pain and suffering, and other damages, asserting that Pfizer’s negligence in informing users about potential risks has led to severe health consequences.
A significant aspect of these claims involves Depo-SubQ Provera 104, a lower-dose version of the original Depo-Provera formulation.
This alternative contains a reduced concentration of medroxyprogesterone acetate and is administered subcutaneously, potentially offering a safer contraceptive option.
Plaintiffs argue that despite having this safer alternative available, Pfizer did not adequately promote or inform healthcare providers and patients about Depo-SubQ Provera 104.
They contend that the company’s continued emphasis on the higher-dose Depo-Provera formulation, without sufficient disclosure of its associated risks, constitutes negligence.
This underpromotion of the lower-dose option is presented as evidence that Pfizer prioritized its own interests over patient safety.
If you’ve developed a brain tumor after receiving Depo-Provera injections for a prolonged period of time, you may be eligible to file a Depo Provera Lawsuit and seek financial compensation.
Contact our Depo-Provera Lawyers for a free consultation, or use the chat feature on this page to find out if you’re eligible to file a Depo Provera Lawsuit instantly.
The Depo Provera Lawsuit is NOT a Class Action Lawsuit
Lawsuits involving Depo-Provera use and brain tumors are not a class action lawsuit but are instead being handled as a multidistrict litigation (MDL).
In a class action lawsuit, all plaintiffs are grouped into a single case, and any compensation is divided equally among participants.
However, in an MDL, each person who files a Depo-Provera lawsuit has an individual claim, meaning their compensation depends on the severity of their injuries and other case-specific factors.
This structure allows women who developed meningiomas after using Depo-Provera to present their unique medical history and damages rather than being treated as part of a single group.
If you or a loved one have suffered serious health complications from long-term Depo-Provera use, you may have the right to sue Pfizer individually while benefiting from the efficiency of MDL proceedings.
Projected Depo-Provera Settlements
Depo-Provera Lawsuits are in the early stages, and specific settlement amounts have yet to be determined.
However, lawyers anticipate that individual Depo-Provera settlements could range from $100,000 to $500,000 or more, depending on various factors.
Factors influencing potential Depo-Provera settlements include:
- Severity of Injuries: The seriousness of the brain tumor and its impact on the individual’s health and daily life.
- Medical Expenses: Costs incurred for treatments, surgeries, hospital stays, medications, and ongoing care.
- Impact on Quality of Life: The extent to which the tumor and its treatment have affected the individual’s physical abilities, mental health, and overall well-being.
- Lost Wages and Earning Capacity: Income lost due to the inability to work during treatment and recovery, as well as any long-term or permanent disability affecting future earning potential.
- Pain and Suffering: Non-economic damages related to physical pain, emotional distress, and mental anguish resulting from the diagnosis and treatment.
It’s important to note that these figures are projections, and actual settlement amounts will depend on the specifics of each case.
If you or a loved one has developed a brain tumor after using Depo-Provera, consulting with an experienced attorney can provide more personalized information regarding potential compensation.
